J&J's Drug Unit Chief Expands Portfolio in Executive Shakeup

Johnson & Johnson’s head of pharmaceuticals, Joaquin Duato, will add the company’s consumer business to his portfolio in an executive shakeup at the U.S. health-care conglomerate.